Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations.

R M BruscaDavid B HannaN I WadaJ N BlanksonM D WittL P JacobsonL KingsleyF J PalellaM BudoffTodd T BrownK AnastosJ M LazarW J MackP BacchettiP C TienY GolzarM PlankeyE GolubR C KaplanW S Post

Published in: HIV medicine (2019)

Subclinical CVD was similar in HIV controllers, LTNPs and HIV-uninfected individuals despite elevated levels of some inflammatory biomarkers. Future studies of HIV controllers and LTNPs are needed to characterize the risk of CVD among HIV-infected persons.

Keyphrases

hiv infected
antiretroviral therapy
hiv positive
human immunodeficiency virus
hiv testing
cardiovascular disease
hiv aids
hepatitis c virus
men who have sex with men
south africa
oxidative stress
current status
metabolic syndrome
cardiovascular events
cardiovascular risk factors